EP1180940A2 - Substance active et combinaison de substances actives pour l'homme et les animaux - Google Patents

Substance active et combinaison de substances actives pour l'homme et les animaux

Info

Publication number
EP1180940A2
EP1180940A2 EP00929249A EP00929249A EP1180940A2 EP 1180940 A2 EP1180940 A2 EP 1180940A2 EP 00929249 A EP00929249 A EP 00929249A EP 00929249 A EP00929249 A EP 00929249A EP 1180940 A2 EP1180940 A2 EP 1180940A2
Authority
EP
European Patent Office
Prior art keywords
active ingredient
ingredient combination
extracts
combination according
colostral milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00929249A
Other languages
German (de)
English (en)
Inventor
Carl-Heinz Kapitz
Gerhard Knapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAPITZ Carl-Heinz
Kind Norbert
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999114646 external-priority patent/DE19914646A1/de
Priority claimed from DE1999163628 external-priority patent/DE19963628A1/de
Priority claimed from DE2000100157 external-priority patent/DE10000157A1/de
Application filed by Individual filed Critical Individual
Priority to DE20023649U priority Critical patent/DE20023649U1/de
Publication of EP1180940A2 publication Critical patent/EP1180940A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206—Colostrum; Human milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter

Definitions

  • the invention relates to an active ingredient and in particular an active ingredient combination for humans and animals, based on colostral milk products and / or colostral milk extracts.
  • Colostral milk or colostrum also known as first or first milk
  • first milk is a secretion of the female mammary glands, usually yellowish due to carotenes, which is often formed during pregnancy, but especially in the first days after birth.
  • Colostrum differs from mature breast milk primarily in its higher protein and vitamin content, especially vitamins A and C, with approximately the same carbohydrate and slightly reduced fat content.
  • Colostrum also has leukocytes loaded with fat drops, the colostrum bodies or colostral bodies.
  • the colostrum which is rich in immunoglobulins, is the first food of the newborn that is important for the first days of life after birth.
  • Health and well-being in humans and animals depend in particular on the food or nutrients ingested and also on how the body processes these substances. These substances can be divided into three different groups of active ingredients. The first shows the substances and active ingredients that are contained in animal products. The second is Mineral group or that of the metal salts with their respective active ingredient content. The third can be assigned to the general plant area. A large number of active ingredients that are contained in the plants are known here.
  • Colostrum of bovine origin has only been available on the market for a few years. It has been possible to gently filter out the valuable ingredients from the colostral milk.
  • the dairy cows produce more colostral milk than the calf needs. Part of the colostral milk is fed to the calves and the other part is brought to the market in a filtered state.
  • Colostral milk extracts are commercially available in the form of granules or as drinkable extracts.
  • Dead Sea Salt extracted from the Dead Sea cleaned and can also be used as a salt bath at home, for example.
  • Dead Sea salt minerals are also used as raw materials for external use in Kos etika.
  • Plant components and / or plant extracts have been known for thousands of years and are used in all areas of health.
  • Active ingredient groups in the individual application are very diverse and still unexplored in many areas, the effectiveness of the three active ingredient groups mentioned above could be demonstrated for internal and external use, especially for the entire skin area.
  • Active ingredient groups contain active ingredients that can have a positive effect on cell metabolism in particular. This has effects in the case of defects in the immune system as well as allergic reactions, skin diseases of various types, neurodermatitis or psoriasis. Furthermore, there are cell regeneration active substances and medicinal substances for the treatment of wounds, sunburn, acne, in the tooth area, skin injuries, all kinds of skin infections, pimples, herpes etc.
  • an active ingredient is now made available which is based on colostral milk products and / or
  • Colostral milk extracts of humans based on sheep and / or goat. Used alone or in the combination of active ingredients explained below, for example as a dietary supplement, food, cosmetic, pharmaceutical and / or as a medicament and as an additive used in cosmetics, beverages, pharmaceuticals, food, nutritional supplements and in the pharmaceutical field, the active ingredient can be used externally and / or are used internally in humans and animals. It has these colostral milk products and / or
  • Human, sheep and / or goat colostrum extracts are significantly different from those of bovine origin and can be used effectively.
  • colostral milk products and / or colostral milk extracts from humans sheep and / or goats in an amount of 0.1 to 60 parts of a hundred, for example
  • Carrier mass ad 100 parts goat colostrum 0.1-60 parts plant extracts 0.1-17 parts testes extracts 0.1-2 parts
  • colostral milk products and / or colostral milk extracts from humans sheep and / or goats are used as food and nutritional supplements according to the invention. These include in particular refreshment and energy drinks and bars with fiber-containing nutrients and fiber.
  • a tablet, powder or capsule form is preferred as a food supplement.
  • Recipe of a capsule as a recipe for a dietary supplement Fruit juice:
  • Vitamin E 2% Vitamin E 5% ß-carotenes 15% colostrum (goat) 35%
  • Formulation of a formulation of an aqueous solution Cream formulation:
  • the present invention further relates to a combination of active substances for human and veterinary use, comprising colostral milk products and / or colostral milk extracts, also of bovine and / or equine origin, in solid, liquid or pasty form or also microencapsulated, in particular enclosed in liposomes; further comprising minerals and / or mineral salts, in particular obtained from the Dead Sea, and further comprising plant components and / or plant extracts, likewise in solid, liquid or pasty form or also microencapsulated, in particular used as a cosmetic, as a medicament, for prophylaxis and therapy Skin irritation of all kinds, as a food, as a food supplement or as a drink, also used as an additive for cosmetics, for medicines, food, food supplements and for beverages.
  • active substances for human and veterinary use comprising colostral milk products and / or colostral milk extracts, also of bovine and / or equine origin, in solid, liquid or pasty form or also microencapsulated, in particular enclosed
  • colostrum The basic components colostrum, minerals, in particular Dead Sea salt, and tea tree oil as a plant extract have so far been used individually in the skin area for skin irritation of all kinds.
  • the active ingredients contained in colostral milk can be taken internally as an extract or as Ointment to be applied externally.
  • the mineral active ingredients used in various skin diseases, especially psoriasis and neurodermatitis, are supplied to humans through a full salt bath through the skin. Not least because of this, sufferers of it travel to the Dead Sea to bathe.
  • the tea tree oil already known as a universal agent, can be used according to experimental studies and clinical studies for burns, mouth and gum infections, cuts and thrush infections. It is also known that colostrum ointment is an excellent remedy for burns and has the reddish spots healed within a very short time.
  • the filtered out colostrum extract or colostrum powder is, apart from small deviations in the substance content, fixed in its composition per liter.
  • Vitamin A ⁇ 150 ⁇ g / 100 ml
  • Vitamin C 270 ⁇ g / 100 ml
  • the mode of action of the colostrum has only been partially researched. So far, it has been found that the growth factors have a positive influence on the cell metabolism and increase the body's immune system.
  • the immunoglobulins support the immune system in preventing and warding off infections and are significantly anti-inflammatory.
  • the amino acids are vital protein building blocks for cellulose change and cell regeneration.
  • Colostrum has special healing properties with regard to skin therapy as a protective substance against bacteria, germs and fungi and leads to a strengthening of the skin tissue.
  • Dead Sea salt Minerals, especially Dead Sea salt, are already present in small amounts in colostral milk, but are not the main focus of colostrum in terms of their importance. In the case of a mixture of colostrum and especially Dead Sea salt, the Dead Sea salt also has its therapeutic effect due to the exceptionally high mine drop content. As with colostrum, the analysis of, for example, Dead Sea salt is fixed down to small deviations per kg.
  • Metal salts in particular obtained from the Dead Sea, are mostly used externally in humans or animals, for example as bath salts, as shampoos, etc. due to their mineral components.
  • Dead Sea salt is particularly valuable for the skin area because it is rich in magnesium and potassium.
  • Magnesium is known as an antiallergen, an important building block for the structural elements of the skin and the enzymes that control the metabolism of the skin. Potassium is an important moisture regulator for the skin. Iodine has a disinfectant and healing effect. Chlorine and sodium are electrolytes dissolved in water and play an important role in
  • Salt concentrations on the skin increases the production of free amino acids.
  • In the foreground of the reactions of the skin metabolism is the activation of proteolytic degradation processes of high-molecular protein compounds.
  • the resulting breakdown products are
  • Peptides with hormone-like effects so that ultimately the ions penetrating the skin can act on the interior of the organism, e.g. on the vascular system, the smooth muscles, on the digestive system and on the autonomic system.
  • the third active ingredient component, plant components and plant extracts also allows countless variation options for the new one due to the large number of plants with their diverse active ingredients in the phyto area
  • Active ingredient combination In particular, because in many cases not only the extract of a plant, but extracts from different plants, in different heights Concentrations, can be used.
  • Aloe Vera strengthens the skin's self-healing
  • avocado oil is soothing and soothing, eucalyptus, geranium, myrrh are antiseptic and antibacterial,
  • Jojoba oil is moisturizing and nourishing, chamomile and lavender are anti-inflammatory,
  • Peppermint oil is cooling and refreshing
  • Sunflower oil contains many vitamins A, D, B and E and has a nourishing effect, tea tree oil is draining and has an antibacterial effect.
  • Colostrum usually has the greatest effect when ingested and its effects are not so long-lasting when used externally.
  • the effect of the Dead Sea salt is particularly good for health when used externally.
  • Colostral milk products and / or colostral milk extracts if these are to be absorbed through the skin, are facilitated and substantially improved by the inventive combination with Dead Sea salt.
  • An improved absorption of the active ingredients of admixed plant extracts is also achieved in this way.
  • colostrum As a natural product, whose unique natural recipe is unlikely to be exactly imitated in laboratories, colostrum has all the vital nonessential and essential amino acids, immunoglobulins and natural growth factors along with vitamins, minerals and lactose and a large number of necessary building materials Fuel substances for the preservation and protection of life.
  • Minerals and / or mineral salts in particular Dead Sea salt as a mineral donor that is unique in the world, complement the minerals that do not contain or only to a small extent in colostrum by a further building block for health, which can affect the entire metabolism of humans, in particular through the skin .
  • the active ingredient combination according to the invention is supplemented by herbal extracts and extracts, and their various modes of action are also used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne un substance active destinée à l'homme et aux animaux, à base de colostrum d'origine humaine, ovine et/ou caprine, ainsi qu'une combinaison de substances actives. La combinaison comprend du colostrum et/ou des extraits de colostrum sous forme solide, fluide, pâteuse ou microencapsulée; des minéraux et des sels minéraux, provenant notamment de la Mer Morte; et des éléments et/ou des extraits végétaux, sous forme solide, fluide ou pâteuse. La composition peut s'utiliser en tant que produit cosmétique ou en tant que médicament, notamment pour la prophylaxie et le traitement dans le domaine cutané, comme soutien en cas d'infection, pour renforcer le système immunitaire, comme aliment, comme complément alimentaire et dans le domaine pharmaceutique, ou bien comme additif dans les aliments, les cosmétiques, les médicaments, les compléments alimentaires ou les boissons.
EP00929249A 1999-03-31 2000-03-29 Substance active et combinaison de substances actives pour l'homme et les animaux Ceased EP1180940A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20023649U DE20023649U1 (de) 1999-03-31 2000-03-29 Wirkstoff und Wirkstoffkombination für Mensch und Tier

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE19914646 1999-03-31
DE1999114646 DE19914646A1 (de) 1999-03-31 1999-03-31 Wirkstoffkombination für Mensch und Tier
DE19963628 1999-12-29
DE1999163628 DE19963628A1 (de) 1999-12-29 1999-12-29 Kolostralmilch von Ziegen und Schafen und deren Verwendung in Kosmetika, Pharmazeutika sowie in Nahrungs- und Nahrungsergänzungsmiteln
DE10000157 2000-01-06
DE2000100157 DE10000157A1 (de) 2000-01-06 2000-01-06 Kolostralmilch (Erstmilch/Stillmilch) vom Menschen (HOMO SAPIENS) und deren Verwendung in Kosmetika, Pharmzeutika sowie in Nahrungs- und Nahrungsergänzungsmitteln
PCT/DE2000/000929 WO2000059519A2 (fr) 1999-03-31 2000-03-29 Substance active et combinaison de substances actives pour l'homme et les animaux

Publications (1)

Publication Number Publication Date
EP1180940A2 true EP1180940A2 (fr) 2002-02-27

Family

ID=27213548

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00929249A Ceased EP1180940A2 (fr) 1999-03-31 2000-03-29 Substance active et combinaison de substances actives pour l'homme et les animaux

Country Status (3)

Country Link
EP (1) EP1180940A2 (fr)
AU (1) AU4742600A (fr)
WO (1) WO2000059519A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG66186B1 (bg) * 2008-01-30 2011-12-30 Сийка ГЕОРГИЕВА Биологично активна хранителна добавка и метод за получаването и

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20005718A (no) * 2000-11-13 2001-06-05 Ethics Cosmeceuticals Ab Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugert vitamin A samt fremgangsmåte for fremstilling og anvendelse av denne
CA2447579A1 (fr) 2001-05-23 2002-11-28 Nutricopia, Inc. Dessert glace nutritif et procedes pour le produire
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
DE10136076A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen
WO2003020048A1 (fr) 2001-08-31 2003-03-13 Nutricopia, Inc. Dessert glace nutritionnel et procedes de fabrication associes
MY142017A (en) * 2004-03-19 2010-08-16 Nestec Sa Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
SG169365A1 (en) 2005-05-02 2011-03-30 4Life Patents Llc Transfer factor preparations and associated methods
US9028882B2 (en) * 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
FR2889058A1 (fr) * 2005-07-26 2007-02-02 Inst Evaluation Dermatophysiqu Composition cosmetique pour la dermabrasion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1220444A (en) * 1967-02-07 1971-01-27 Evagoras Joannou Georgiou Preparation of active substances for the treatment of malignant tumours
JPS553721A (en) * 1978-06-21 1980-01-11 Morinaga Milk Ind Co Ltd Production of powder of colostrum
EP0675708B1 (fr) * 1993-01-26 1997-04-09 Horse Vitality Ltd. Compositions pharmaceutiques et dermocosmetiques contenant du colostrum d'equide
CN1105270A (zh) * 1994-01-14 1995-07-19 中国韬奋基金会 含分泌型免疫球蛋白a的制品及其制备方法
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
DE19619990A1 (de) * 1996-05-17 1997-11-20 Charlotte Adler Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung
IT1291340B1 (it) * 1997-05-09 1999-01-07 Vander Way Limited Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
WO1998053836A1 (fr) * 1997-05-27 1998-12-03 Anderson Michael R Produits gelifies ameliores contenant de l'oxygene actif
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0059519A2 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG66186B1 (bg) * 2008-01-30 2011-12-30 Сийка ГЕОРГИЕВА Биологично активна хранителна добавка и метод за получаването и

Also Published As

Publication number Publication date
WO2000059519A2 (fr) 2000-10-12
AU4742600A (en) 2000-10-23
WO2000059519A3 (fr) 2001-01-11

Similar Documents

Publication Publication Date Title
EP0155344B1 (fr) Composition pour les soins de la peau
EP1096918B1 (fr) Agent de soin et/ou de traitement de la peau et de tissus
DE60034667T2 (de) Pharmazeutische zusammensetzung aus komplexen kohlenhydraten und deren anwendung
KR20110131498A (ko) 패각 또는 패산호로부터 추출한 알카리용액에 은이온을 포함하는 항균제와 이를 포함하여 조성된 조성물.
JPH1053532A (ja) 植物抽出物含有抗アレルギー剤
JPH09110710A (ja) 皮膚外用剤及び浴用剤
JPH0987189A (ja) エンメイソウ、ボタンピ、シソ、アルニカ含有抗アレルギー剤
CN112472653A (zh) 一种祛痘芦荟胶及其制备方法
WO2000059519A2 (fr) Substance active et combinaison de substances actives pour l&#39;homme et les animaux
CH677319A5 (de) Kosmetische mittel zur gesundheits- und koerperpflege oder arzneimittel.
DE19914646A1 (de) Wirkstoffkombination für Mensch und Tier
Kumara et al. Pharmaceutical, nutritional and cosmetic applications of Aloe vera plant
RU2593339C2 (ru) Натуральный лекарственный состав
KR102801893B1 (ko) 나노화된 벌화분 추출물을 유효성분으로 포함하는 여드름 치료용 조성물
CH682631A5 (de) Präparat zur Förderung des Haarwuchses.
DE20023649U1 (de) Wirkstoff und Wirkstoffkombination für Mensch und Tier
DE69426495T2 (de) Weizensprossensaft enthaltendes stabiles präparat und verfahren zu seiner herstellung
RU2218387C1 (ru) Минерально-хвойный комплекс
WO2009065946A2 (fr) Système pharmaceutique constitué d&#39;une émulsion huile dans l&#39;eau et d&#39;une composition solide
CN1095919A (zh) 红景天系列化妆品
WO2006108414A2 (fr) Agent pour assurer la therapie et la prophylaxie de maladies de la peau
US20210290711A1 (en) Hempseed oil compositions
US20040228928A1 (en) Method of altering, enhancing and standardizing the potency and bioactivity of bioactive polysaccharides
DE102010016134A1 (de) Verfahren zur Herstellung eines Konzentrates aus Kamelmilch
WO2011089012A2 (fr) Utilisation d&#39;un mélange de substances naturelles à base de grappes de ceratonia siliqua comme produit médicamenteux

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011116

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20050321

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KAPITZ, CARL-HEINZ

Owner name: KIND, NORBERT

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20120803